Close
Nordic 9Nordic 9

Asarina Pharma (private company)

Sweden asarinapharma.com
See something wrong or missing? Let us know
Offices:Stockholm
Industry:Health servicesPharma
Business model:B2B

Asarina Pharma, formerly known as Umecrine Mood, founded by Torbjörn Bäckström, focuses on the development of Sepranolone (UC1010) for the treatment of premenstrual dysphoric disorder and other menstrually related conditions, which has shown promising results in an exploratory clinical Phase I/II study.

Asarina Pharma went into voluntary liquidation in 2025.

Investors: we tracked 4 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 13.2M

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Asarina Pharma

Name Criteria
Spain Bigfinite
53%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
Finland Forendo Pharma
53%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
Sweden Gesynta Pharma
53%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
Denmark NMD Pharma
53%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Spain Ona Therapeutics
53%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
United Kingdom ReViral
53%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
Spain Sanifit Therapeutics
53%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
Denmark STipe Therapeutics
53%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Switzerland T3 Pharmaceuticals
53%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Sweden Trialbee
53%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Top